Literature DB >> 7531965

Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous Kaposi's sarcoma.

S Poignonec, L D Lachiver, G Lamas, A Coutellier, E Caumes, J Soudant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7531965     DOI： 10.1001/archderm.131.2.228b

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  3 in total

Review 1.  A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.

Authors:  G Nasti; D Errante; S Santarossa; E Vaccher; U Tirelli
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

2.  Successful treatment of nodular human immunodeficiency virus-associated Kaposi sarcoma of the foot utilizing combination intralesional bleomycin and cryotherapy.

Authors:  Maia K Erickson; Jennifer N Choi
Journal:  JAAD Case Rep       Date:  2021-02-10

3.  Effective treatment of HIV-associated Kaposi sarcoma in the setting of immune-reconstitution inflammatory syndrome using intralesional bleomycin.

Authors:  Brittany Ehlert; Rachel Delost; Vinaya Soundararajan; Gregory Delost; Danny Barlev
Journal:  JAAD Case Rep       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.